Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fernando

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Psychopharmacology|January 1, 1990
Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humansA L Sharpley, R A Solomon, A I Fernando, et al.
British Journal of Cancer|April 1, 1993
Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigenS M Allan, C Dean, I Fernando, et al.
Cell Death & Disease|June 22, 2013
The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapiesB Huang, J R Cohen, R I Fernando, et al.
Physical Chemistry Chemical Physics : PCCP|July 5, 2024
Periodic DFT calculations to compute the attributes of a quantum material: honeycomb ruthenium trichlorideAshlyn M Koval, Glen R Jenness, Timothy C Schutt, et al.
Reproductive Biology and Endocrinology : RB&E|May 13, 2003
Placental expression of estrogen receptor beta and its hormone binding variant--comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cellsAntonin Bukovsky, Michael R Caudle, Maria Cekanova, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 30, 2008
Selective axillary node sampling and radiotherapy to the axilla in the management of breast cancerJ S Tanguay, D R Ford, G Sadler, et al.
Oncotarget|October 16, 2013
Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccineDuane H Hamilton, Mary T Litzinger, Alessandra Jales, et al.
Vaccine|April 9, 2017
Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7Kwong Y Tsang, Massimo Fantini, Romaine I Fernando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapyClaudia Palena, Dmitry E Polev, Kwong Y Tsang, et al.
Ebiomedicine|July 25, 2020
The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagusWladyslaw Januszewicz, Vinod V Subhash, William Waldock, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Psychopharmacology|January 1, 1990
Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humansA L Sharpley, R A Solomon, A I Fernando, et al.
British Journal of Cancer|April 1, 1993
Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigenS M Allan, C Dean, I Fernando, et al.
Cell Death & Disease|June 22, 2013
The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapiesB Huang, J R Cohen, R I Fernando, et al.
Physical Chemistry Chemical Physics : PCCP|July 5, 2024
Periodic DFT calculations to compute the attributes of a quantum material: honeycomb ruthenium trichlorideAshlyn M Koval, Glen R Jenness, Timothy C Schutt, et al.
Reproductive Biology and Endocrinology : RB&E|May 13, 2003
Placental expression of estrogen receptor beta and its hormone binding variant--comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cellsAntonin Bukovsky, Michael R Caudle, Maria Cekanova, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 30, 2008
Selective axillary node sampling and radiotherapy to the axilla in the management of breast cancerJ S Tanguay, D R Ford, G Sadler, et al.
Oncotarget|October 16, 2013
Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccineDuane H Hamilton, Mary T Litzinger, Alessandra Jales, et al.
Vaccine|April 9, 2017
Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7Kwong Y Tsang, Massimo Fantini, Romaine I Fernando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapyClaudia Palena, Dmitry E Polev, Kwong Y Tsang, et al.
Ebiomedicine|July 25, 2020
The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagusWladyslaw Januszewicz, Vinod V Subhash, William Waldock, et al.
Pageof 8